Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/K27 stock hub

FRA/K27 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/K27is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.2B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/K27

In the news

Latest news · FRA/K27

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-74.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/K27 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

116

Groups with data

Currency

USD

Showing 116 of 116 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	124
Employees Change	15%
Employees Change Percent	13.89
Enterprise value	EUR 2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 2.2B
Price	EUR 35.55
Price currency	EUR
Sic	2836
Symbol	fra/K27
Website	https://kodiak.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.26%
EV Earnings	-10.16x
P/B ratio	15.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -200.1M
Profit Per Employee	EUR -1.6M
Roa5y	-29.13
Roe5y	-80.83
ROIC	-74.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	992.28%
Cagr3y	105.59%
Cagr5y	-15.6%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	EUR 182M
Debt	EUR 51.3M
Debt Equity	EUR 0.38
Equity	EUR 136.5M
Net Cash	EUR 130.7M
Net Cash By Market Cap	EUR 6.05
Net Cash Growth	111.6%
Net Debt Equity	EUR -0.96
Tangible Book Value	EUR 136.5M
Tangible Book Value Per Share	EUR 2.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	990.49%
200-day SMA	18.67
3Y total return	769.41%
50-day SMA	29.27
50-day SMA vs 200-day SMA	50over200
5Y total return	-57.17%
All Time High	134
All Time High Change	-73.47%
All Time High Date	2021-01-20
All Time Low	1.23
All Time Low Change	2,797.31%
All Time Low Date	2023-10-26
ATR	2.19
Ch YTD	48.25
High	36.91
High52	39.74
High52 Date	2026-04-21
High52ch	-10.54%
Low	35.55
Low52	2.87
Low52 Date	2025-05-16
Low52ch	1,139.54%
Ma50ch	21.47%
Price vs 200-day SMA	90.44%
RSI	51.71
RSI Monthly	74.01
RSI Weekly	67.7
Sharpe ratio	1.99x
Sortino ratio	4.64
Total Return	-5.4%
Tr YTD	48.25
Tr1m	3.34%
Tr1w	-4.41%
Tr3m	94.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -203.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,871,763%
Shares Insiders	5.11%
Shares Institutions	57.73%
Shares Qo Q	13.64%
Shares Yo Y	5.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	42.9x
Bv Per Share	2.21
Ch1m	3.34
Ch1w	-4.41
Ch1y	990.5
Ch3m	94.37
Ch3y	769.4
Ch5y	-57.17
Ch6m	147.6
Change	-8.23%
Change From Open	-3.68
Close	38.74
Days Gap	-4.72
Depreciation Amortization	15,523,640.3
Dollar Volume	7,110
Earnings Date	2026-05-14
EBIT	EUR -203.9M
EBITDA	EUR -188M
EPS	EUR -3.61
F Score	0
Fiscal Year End	December
Founded	2,009
Is Primary Listing	0
Last Earnings Date	2025-11-20
Last Report Date	2026-03-31
Ma150	22.15
Ma150ch	60.51%
Ma20	37.28
Ma20ch	-4.64%
Next Earnings Date	2026-05-14
Open	36.91
Position In Range	0
Price Date	2026-05-08
Ptbv Ratio	15.83
Relative Volume	4.66x
Tr6m	147.56%
Volume	200

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/K27 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/K27 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/K27?

Insider, institutional, and short-interest positioning.

Institutional ownership

+57.7%

Share of float held by funds and institutions

Insider ownership

+5.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.4%

Negative means the company is buying back shares.

Technical

FRA/K27 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.7

Neutral momentum band

Price vs 200-day MA

+90.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.99

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/K27

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/K27 stock rating?

fra/K27 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/K27 analysis?

The full report lives at /stocks/fra/K27/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/K27?

The latest report frames fra/K27 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/K27 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.